{"id":401016,"date":"2020-12-16T09:18:33","date_gmt":"2020-12-16T14:18:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401016"},"modified":"2020-12-16T09:18:33","modified_gmt":"2020-12-16T14:18:33","slug":"oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/","title":{"rendered":"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week"},"content":{"rendered":"<div class=\"mw_release\">\n<p>OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec.  16, 2020  (GLOBE NEWSWIRE) &#8212; Oxford Immunotec Global PLC (Nasdaq: OXFD) (the \u201cCompany\u201d), a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell expert consortium (GTEC). The GTEC is a community of experts in T cell research, epidemiology, vaccine research and global public health. It aims to be the leading voice for T cell expertise during and beyond the current COVID-19 pandemic.<\/p>\n<p>The GTEC is an independent forum, with its agenda, research and associated education driven by the consortium experts, with support from Oxford Immunotec.<\/p>\n<p>The goal of the GTEC is to advance the frontiers of T cell research and education and to raise the profile of T cells to the level of antibodies in the mind of doctors, governments and the public. This is in recognition of the key role T cells play in immunity, and the specific role they play in COVID-19. To achieve this goal the GTEC will:<\/p>\n<ul type=\"disc\">\n<li>Drive further research into the role of T cell measurement for COVID-19<\/li>\n<li>Drive education on the role of T cells in immunity<\/li>\n<li>Stimulate creation of new, innovative research studies by facilitating enhanced networking amongst T cell researchers<\/li>\n<\/ul>\n<p>Danny Altman, Professor of Immunology at Imperial College London, is the first chair of the GTEC. In addition, 10 other leading T cell experts have joined the consortium from the USA, Europe and Asia (the complete membership of the consortium, with individual biographies, is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UhmTzWUehQIJ23qo4XAG9pcbEEGtfwxzjxPFrwcVcnSJj1AWKkXa8l4UaStGAQTZsdhObZ9B2wKH1Ul9qyQffValnRkEWdM_TOObzXBNIuk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.tcellexperts.com<\/a>).<\/p>\n<p>Dr Andrew Makin, VP Medical Affairs at Oxford Immunotec, said, \u201cThis independent consortium of leading T cell researchers will provide a unique forum for education and research into the role of T cells, particularly in relation to COVID-19. The consortium are already developing the first podcasts and webinars which will form part of the educational materials that will come out of this group.\u201d<\/p>\n<p>Dr Peter Wrighton-Smith, CEO of Oxford Immunotec, said, \u201cWe are proud to be supporting this T cell initiative of such global significance. It will help to improve the understanding of T cells by both specialists and the general public, and drive forward the search for additional knowledge in the T cell field for the benefit of us all.\u201d<\/p>\n<p>For additional information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UhmTzWUehQIJ23qo4XAG9s_ahiwNjtWzB-BfTNb8dSkJq1uOZEpRJM0sAP76O3ZAuAuFKQou2KAvvAfcyxw7D0dZclBgBreFfanp0QFBOhE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.tcellexperts.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Oxford Immunotec<\/strong>\n      <\/p>\n<p align=\"justify\">Oxford Immunotec Global PLC is a global, high-growth diagnostics company. We bring energy and invention to a world in need of diagnostic truth. We are uniquely placed as the only company in the world offering regulated ELISPOT assays for T cell measurement, with approval around the globe. Our leading product, the T-SPOT<sup>\u00ae<\/sup>.<em>TB<\/em> test, is used for diagnosing infection with Tuberculosis, the world\u2019s largest cause of death from infectious disease. The Company is an experienced manufacturer of IVD tests, operating under a fully audited Quality Management System, ensuring rigorous batch control. The company has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT.<em>TB<\/em> test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. In addition, the Company has released the research use only T-SPOT <em>Discovery<\/em> SARS-CoV-2 test, which uses this same T-SPOT<sup>\u00ae<\/sup> technology as the T-SPOT.<em>TB<\/em> test to allow SARS-CoV-2-specific T cells to be detected and enumerated. The Company\u2019s single antigen-per-well approach allows specific information about the immune response to different SARS-CoV-2 antigens to be gathered in parallel. Sample processing can be centralised whilst still enabling testing on fresh (rather than frozen) blood, using the Company\u2019s T-Cell <em>Xtend<\/em><sup>\u00ae<\/sup> reagent (32 hr room temperature (RT) sample stability). The Company is headquartered near Oxford, U.K. and in Marlborough, MA. Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uc07S5xlQ5ecG3ywZ1Nm62jx-lHFx8w15QX7vXDSUcz_JQrTnnYUHSsrpuGD63BHBf2ibeoFYfoyERyQs1699CyTgrcmlkDgywgV0TbUqc4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.oxfordimmunotec.com<\/a>.<\/p>\n<p align=\"justify\">T-SPOT, the Oxford Immunotec logo, and T-Cell <em>Xtend<\/em> are trademarks of Oxford Immunotec Limited.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this release are forward-looking statements. This includes statements about Oxford Immunotec\u2019s anticipated plans and objectives, future performance and revenues, financial condition, prospects for sales of its products, growth, strategies, expectations and objectives of management. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements contained in this release reflect Oxford Immunotec\u2019s current expectations and are subject to risks and uncertainties. Actual results may differ materially from those projected or implied by forward-looking statements. Other factors that could adversely affect Oxford Immunotec\u2019s business and prospects are described under the \u201cRisk Factors\u201d section in its filings with the Securities and Exchange Commission (\u201cSEC\u201d). Oxford Immunotec\u2019s SEC filings are available for free by visiting the investor section of its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uc07S5xlQ5ecG3ywZ1Nm62jx-lHFx8w15QX7vXDSUcwbMP4Fxqt43dg3fUAyusvlbvWso9RLM4B_tklK9FwGuduj-FimQQjRSEJUXUku8So=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.oxfordimmunotec.com<\/a>, or the SEC\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pHj1njws-5iOplNAMNUxmdCrEIjxVxTVkf2Pw4hwFEbItQ35tD2Mpb7kNlV-widTYv7a--l2HS8IocPRKXkkCQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.sec.gov<\/a>.<\/p>\n<p align=\"justify\">Investors should give careful consideration to these risks and uncertainties. Forward-looking statements contained herein are based on current expectations and assumptions and currently available data and are neither predictions nor guarantees of future events or performance. Investors should not place undue reliance on forward-looking statements contained herein, which speak only as of the date of this release. Oxford Immunotec does not undertake to update or revise any forward-looking statements after they are made, whether as a result of new information, future events, or otherwise, except as required by applicable law.<\/p>\n<p align=\"justify\">\n        <strong>For Investor Inquiries: <\/strong><br \/>\n        <br \/>Matt McLaughlin<br \/>Chief Financial Officer<br \/>Oxford Immunotec<br \/>Tel: +1 (508) 573-9953<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YlalMXSkzThh-eYvoD7OR8x08eNtyChz4hmqzAATjbSGmXGD0f6i385UStRus3IhjgRWsguszEqpdEhKqO26zefk22zXYTlbPtVkS-BX2Ge0ik1wiyoJ87odxibK_6ZM\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mtmclaughlin@oxfordimmunotec.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/1d1f9291-bfbf-4ac4-8972-0f640420352f\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Oxford Immunotec Global PLC (Nasdaq: OXFD) (the \u201cCompany\u201d), a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell expert consortium (GTEC). The GTEC is a community of experts in T cell research, epidemiology, vaccine research and global public health. It aims to be the leading voice for T cell expertise during and beyond the current COVID-19 pandemic. The GTEC is an independent forum, with its agenda, research and associated education driven by the consortium experts, with support from Oxford Immunotec. The goal of the GTEC is to advance the frontiers of T cell research and education and to raise the profile of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401016","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Oxford Immunotec Global PLC (Nasdaq: OXFD) (the \u201cCompany\u201d), a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell expert consortium (GTEC). The GTEC is a community of experts in T cell research, epidemiology, vaccine research and global public health. It aims to be the leading voice for T cell expertise during and beyond the current COVID-19 pandemic. The GTEC is an independent forum, with its agenda, research and associated education driven by the consortium experts, with support from Oxford Immunotec. The goal of the GTEC is to advance the frontiers of T cell research and education and to raise the profile of &hellip; Continue reading &quot;Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-16T14:18:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week\",\"datePublished\":\"2020-12-16T14:18:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/\"},\"wordCount\":936,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/\",\"name\":\"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=\",\"datePublished\":\"2020-12-16T14:18:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/","og_locale":"en_US","og_type":"article","og_title":"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week - Market Newsdesk","og_description":"OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Oxford Immunotec Global PLC (Nasdaq: OXFD) (the \u201cCompany\u201d), a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell expert consortium (GTEC). The GTEC is a community of experts in T cell research, epidemiology, vaccine research and global public health. It aims to be the leading voice for T cell expertise during and beyond the current COVID-19 pandemic. The GTEC is an independent forum, with its agenda, research and associated education driven by the consortium experts, with support from Oxford Immunotec. The goal of the GTEC is to advance the frontiers of T cell research and education and to raise the profile of &hellip; Continue reading \"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-16T14:18:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week","datePublished":"2020-12-16T14:18:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/"},"wordCount":936,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/","name":"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=","datePublished":"2020-12-16T14:18:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzI3MyMzODgyMjM1IzIwMjMwMjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oxford-immunotec-announces-the-foundation-of-the-global-t-cell-expert-consortium-whose-first-meeting-took-place-this-week\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401016"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401016\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}